Ago Research Gmbh

This study is testing if giving cancer drugs *before* surgery is a safe and workable strategy for advanced ovarian cancer. It will enroll 60 patients into two groups: one receives the drug olaparib, and the other receives olaparib plus durvalumab. The main goal is to see if patie…

This study is testing whether a combination of two existing cancer drugs, pembrolizumab and lenvatinib, can help control advanced vulvar cancer that has returned or spread and cannot be treated with surgery or radiation. It will enroll about 42 patients to see if the combination …